BRTX - Why BioRestorative Therapies Stock Is Up Today | Benzinga
BioRestorative Therapies, Inc. (NASDAQ:BRTX) shares are trading higher Monday after the company presented preliminary clinical data from its ongoing Phase 2 clinical trial of the company’s lead clinical candidate, BRTX-100, in subjects with chronic lumbar disc disease.
The Details:
BioRestorative Therapies presented the data at the Orthopaedic Research Society 2024 Annual Meeting on Sunday and hosted a webcast and ...